Introduction
Table of Contents
Yeast infections, particularly caused by Candida and Cryptococcus species, are a major clinical challenge, especially in immunocompromised patients. Rapid and accurate determination of antifungal susceptibility is crucial for guiding therapy. The E-test (Epsilometer test) is a widely used, simple, and reliable method for determining the minimum inhibitory concentration (MIC) of antifungal agents against yeasts. It combines the ease of disk diffusion with the quantitative accuracy of broth microdilution.
Principle
- The E-test uses a plastic strip impregnated with a predefined gradient of antifungal drug concentrations (e.g., fluconazole, voriconazole, amphotericin B, caspofungin).
- The strip is placed on the surface of an agar plate (usually RPMI agar with glucose and MOPS buffer) previously inoculated with a standardized suspension of yeast.
- During incubation, the antifungal diffuses from the strip into the agar, establishing a stable gradient.
- After 24–48 hours, an elliptical inhibition zone forms around the strip.
- The MIC value is read directly from the scale on the strip at the point where the ellipse intersects the strip.
Clinical Significance
- Rapid MIC Determination – Provides accurate MIC values for antifungals without the need for complex equipment.
- Broad Applicability – Effective for testing Candida spp., Cryptococcus spp., and other clinically important yeasts.
- Therapeutic Guidance – Helps clinicians choose the most effective antifungal agent for patient treatment.
- Detection of Resistance – Identifies resistance to azoles, echinocandins, or amphotericin B.
- User-Friendly – Simpler than CLSI broth microdilution, making it suitable for routine labs.
- Quality Control – Used for validating automated systems (e.g., VITEK 2) or confirming unusual results.
Keynotes
- E-test is a quantitative, gradient diffusion method that provides MIC values for yeasts.
- It is easier to perform than broth microdilution (CLSI/ EUCAST) but slightly more expensive.
- Results are usually available within 24–48 hours, depending on the yeast species.
- Works well for Candida albicans, C. glabrata, C. auris, Cryptococcus neoformans, etc.
- Interpretation relies on clinical breakpoints (CBPs) or epidemiological cutoff values (ECVs).
- Limitations include cost per strip, potential variation in endpoint reading, and lower reproducibility compared to standardized reference methods.
- Despite limitations, the E-test remains a practical alternative in clinical microbiology laboratories, especially where reference methods are unavailable.
Further Readings
- https://www.mdpi.com/2309-608X/5/4/108#:~:text=Abstract,MIC)%20in%20%C2%B5g/mL.
- https://www.researchgate.net/file.PostFileLoader.html?id=53f218c3d039b1bc6b8b45c3&assetKey=AS%3A273580883939331%401442238173115
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6958406/
- https://health.maryland.gov/laboratories/docs/Etest%20information.pdf
- https://www.cdc.gov/fungal/hcp/laboratories/afst-of-yeasts-by-gradient-diffusion.html
- https://microbenotes.com/epsilometer-test-e-test/
- https://www.biomerieux.com/us/en/our-offer/clinical-products/etest.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6958406/